Description
GLP3-RTA is a single-chain synthetic research peptide engineered as a triple-receptor agonist, supplied as a lyophilized powder for controlled laboratory study of next-generation incretin and energy-metabolism pathways.
Research context — Investigators use GLP3-RTA in vitro to explore signaling across the three metabolic receptor families it targets, and how simultaneous activation compares with single- and dual-receptor reference compounds.
Why this grade — Every batch is ≥99% pure by HPLC, confirmed by an independent third-party laboratory for identity and fill weight, US-sourced, with a current Certificate of Analysis on file.




Reviews
There are no reviews yet.